ZNF382 was firstly identified as a direct repressor for several oncogenes (i.e., MYC, MITF, HMGA2, and CDK6) across distinct types of cancers, including lung, esophageal, colon, stomach, breast, and cervical tumors [50]. Here, HMGA2 is linked to cancer.